At the preclinical level, in vitro, quercetin inhibits hypoxia-related HIF-1α protein accumulation and VEGF release in breast cancer cell lines primarily through inhibition of HIF-1α protein synthesis [63]. The gene discussed is HIF1A; the disease is breast carcinoma.